首页>
外国专利>
monoaminakridinen deficiency of cholinergic nervous system in
monoaminakridinen deficiency of cholinergic nervous system in
展开▼
机译:monoaminakridinen胆碱能神经系统缺乏症
展开▼
页面导航
摘要
著录项
相似文献
摘要
A method for treating central nervous system or peripheral nervous system cholinergic deficit states such as Alzheimer's disease in a mammal, said method comprising administering to said mammal an amount of a monoamine acridine derivative effective in the treatment of a cholinergic deficit state and for a time sufficient to achieve a suitable blood level to treat said cholinergic deficit state. The preferred monoamine acridine derivative is 1,2,3,4-tetrahydro-5-aminoacridine. A unit dosage pharmaceutical composition of matter comprising an effective amount of said monoamine acridine derivative sufficient to treat said cholinergic deficit state and a pharmaceutically acceptable inert carrier therefor is also described.
展开▼